Pablo Aschner

6.2k citations
93 papers · 4.3k · 3 hit papers · h-index 34

Impact in

    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Diabetes Management and Education
  • Genetics top 5%
    • Diabetes and associated disorders

Papers in

    • Diabetes Management and Research 25
    • Diabetes, Cardiovascular Risks, and Lipoproteins 24
    • Diabetes Treatment and Management 18
    • Diabetes Management and Education 11
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
    • Diabetes and associated disorders 9

Pablo Aschner

88 papers receiving 4.1k citations

Pablo Aschner's Hit Papers

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management 2019 · 364 citations
3640+6+13Years since publication200400600

Peers

Pablo Aschner
Comparison fields: 5 of 139
  • Endocrinology, Diabetes and Metabolism 2.4k
  • Genetics 466
  • Surgery 577
  • Pharmacology 216
  • Family Practice 22
Replace Ho‐Young Son with:
Ho‐Young Son South Korea
Helena W. Rodbard United States
Billy S. Collins United States
Jae Hyeon Kim South Korea
Ranjit Unnikrishnan India
Tsvetalina Tankova Bulgaria
Diana Isaacs United States
Marília Brito Gomes Brazil
Dorte Vistisen Denmark
Fernando Ovalle United States
Pablo Aschner relative to Ho‐Young Son South Korea Ho‐Young Son's profile →
Citations per field
00.5×1.5×2.4×
Ho‐Young Son · 1×
Citations per year

Countries citing papers authored by Pablo Aschner

Since Specialization
Citations

This map shows the geographic impact of Pablo Aschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Aschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Aschner more than expected).

Fields of papers citing papers by Pablo Aschner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Aschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Aschner. The network helps show where Pablo Aschner may publish in the future.

Co-authors

The 25 scholars most cited alongside Pablo Aschner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pablo Aschner Line = papers co-authored together Pablo Aschner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Hit paper breakdown →
2006721
2
ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents
Hit paper breakdown →
2018440
3
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
Hit paper breakdown →
2019364
4 2008224
5 2009135
6 2014128
7 2008127
8 2017114
9 2011109
10 200696
11 201595
12 202086
13 202086
14 201282
15 201374
16 200269
17 201568
18 201066
19 202263
20 201061

About Pablo Aschner

Pablo Aschner is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, General Health Professions, Public Health, Environmental and Occupational Health and Surgery, having authored 93 papers that have together received 4.3k indexed citations. Recurring topics across this work include Diabetes Management and Research (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Diabetes Treatment and Management (18 papers), Diabetes Management and Education (11 papers), Diabetes and associated disorders (9 papers), Health and Lifestyle Studies (6 papers), Obesity, Physical Activity, Diet (5 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.4k citations), Genetics (466 citations), Surgery (577 citations), Pharmacology (216 citations) and Family Practice (22 citations). Pablo Aschner has collaborated with scholars based in Colombia, United States and Argentina. Frequent co-authors include Debora Williams‐Herman, Carolyn Mickel, Mark Kipnes, Jared Lunceford, Juliana C.N. Chan, Maria E. Craig, Anna R. Kahkoska, Craig Jefferies, N.M. Baldé and Elizabeth J. Mayer‐Davis. Their work appears in journals such as Diabetes, Diabetes Research and Clinical Practice, Value in Health, Diabetes Care and Diabetes Obesity and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact